The biopharmaceutical industry has risen to the challenge of the COVID-19 pandemic with dozens of vaccine and therapeutic candidates in development, helping biopharma stocks outperform stocks in many other industries.
Finance Watch: Biotech Stocks Down, But Holding Up Better Than Broader Indices
Public Company Edition: Benefitting from hope that biopharma interventions will help the coronavirus pandemic, the industry is faring better than others in the stock market, including the ability to launch IPOs. Also, BridgeBio leads recent financings and PDL is on track to dissolve by year-end.
